Novartis drug Signifor® LAR shows superior efficacy in acromegaly patients not controlled on first generation somatostatin analogues

Novartis drug Signifor® LAR shows superior efficacy in acromegaly patients not controlled on first generation somatostatin analogues

May 05, 2014
Source URL: https://qa1.novartis.us/us-en/news/media-releases/novartis-drug-signifor-lar-shows-superior-efficacy-acromegaly-patients-not-controlled-first-generation-somatostatin-analogues-0

List of links present in page
  1. https://qa1.novartis.us/us-en/us-en/news/media-releases/novartis-drug-signifor-lar-shows-superior-efficacy-acromegaly-patients-not-controlled-first-generation-somatostatin-analogues-0